Screening for carcinoma of the prostate: Efficacy of available screening tests
β Scribed by Ian M. Thompson; William R. Fair
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 683 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Despite the ongoing controversy regarding the utility of prostate carcinoma (pca) screening, the prevalence of asymptomatic men who participate in free pca screening programs is on the rise. however, this increased awareness has not been associated with increased knowledge about the
Estimates of cost-effectiveness for prostate carcinoma screening require a review of current data, modeling efforts, and perspectives on societal impact and costs. ## METHODS. Recent data from the cancer registry of the Michigan Department of Community Health was assessed for incidence trends in r
## BACKGROUND. There is limited information on outcomes of prostate carcinoma treatments given to screened patient populations for whom cancer is usually detected at an earlier stage. ## METHODS. The authors conducted a cross-sectional evaluation of quality-of-life outcomes for men with prostate
## Abstract MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression via posttranscriptional inhibition of protein synthesis. They play a vital role in tumorigenesis. To characterize the diagnostic potential of miRNAs in prostate cancer, a leading cause of cancer mortality, we perfo